Bhutan vs Syrian Arab Republic: Average cost of tuberculosis treatment by type
Bhutan
12 constant 2022 US$
in 2024
Syrian Arab Republic
12 constant 2022 US$
in 2024
Bhutan rank
45th
Syrian Arab Republic rank
45th
Average cost of tuberculosis treatment by type over time
- Bhutan
- Syrian Arab Republic
How they compare
Bhutan currently reports 12 constant 2022 US$ against 12 constant 2022 US$ in Syrian Arab Republic, a difference of 0 constant 2022 US$.
Across all 6 years both countries report, Syrian Arab Republic has been ahead every year.
Bhutan ranks 45th and Syrian Arab Republic ranks 45th of 62 countries.
Syrian Arab Republic has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bhutan | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 7 constant 2022 US$ | 17 constant 2022 US$ | 10 constant 2022 US$ | Syrian Arab Republic |
| 2020s | 13.6 constant 2022 US$ | 16.8 constant 2022 US$ | 3.2 constant 2022 US$ | Syrian Arab Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of tuberculosis treatment by type, Bhutan or Syrian Arab Republic?
- Bhutan, at 12 constant 2022 US$ against 12 constant 2022 US$ in Syrian Arab Republic as of 2024.
- What is the difference in average cost of tuberculosis treatment by type between Bhutan and Syrian Arab Republic?
- 0 constant 2022 US$, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Syrian Arab Republic?
- 6 years are reported by both, from 2019 to 2024.
- How do Bhutan and Syrian Arab Republic rank globally for average cost of tuberculosis treatment by type?
- Bhutan ranks 45th and Syrian Arab Republic ranks 45th of 62 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of tuberculosis treatment by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per person starting tuberculosis preventive treatment, excluding buffer stock.